Bjørgvin DPS
Bergen, Norway
Location status: Recruiting
NCT Number: NCT06299189
The primary objective of this study is to explore and evaluate the use and utility of a guided Internet-delivered psychological treatment for adults with ADHD with a combined focus on:
i) Evaluating the impact of potential predictors to treatment adherence, treatment response, treatment use and utilty. ii) Evaluating the feasibility, clinical benefits and implementation process of the treatment in routine outpatient care. iii) Evaluate the cost-effectiveness of the treatment program.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Bergen, Norway
Location status: Recruiting
Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by symptoms of inattention and/or hyperactivity/impulsivity that are persistent across time and situations. ADHD in adulthood, with estimated prevalence of 2-3%, is associated with challenges that may have severe consequences on daily life functioning. Treatments delivered over the Internet on smartphones or personal computers may help to increase the availability of effective psychological interventions for a larger group of adults with ADHD. The overall aim of this study is to investigate 1) predictors of effect; 2) implementation outcomes; and the 3) cost-benefit of a therapist guided Internet-delivered treatment for adults with an ADHD diagnosis. The study is an open longitudinal cohort trial in routine care. A total of 200 participants with an ADHD diagnosis will be included in the trial, and 15 participants will be interviewed about their experiences with guided Internet-delivered treatment. The outcomes are change in primary and secondary symptoms and quality of life, cost-benefit and implementation outcomes of guided internet-delivered treatment for adults with ADHD. The investigators will use quantitative statistical procedures and qualitative methods to analyze the data. The results from the study will contribute to the growing research on Internet-delivered treatments. The expected results may have a major impact on treatment provision and the further development of treatment options for adults with ADHD. Moreover, investigating ways to increase adoption, adherence and fidelity in Internet-delivered treatment could be of great value when implementing such treatment into routine care.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
|
Exclusion criteria
Guided self-help, 7 modules Interventions
Time frame: From enrollment to the end of 6-months follow-up
Measure of ADHD symptom severity
Time frame: From enrollment til the end of 6-month follow-up.
Measure of impact of ADHD on quality of life
Time frame: From enrollment til the end of 6-month follow-up.
Measure of depression
Time frame: From enrollment til the end of 6-month follow-up.
Measure of anxiety
Time frame: From enrollment til the end of 6-month follow-up.
Measure of personality functioning
Time frame: From enrollment to end of 6-month follow-up.
Measure of health-related quality of life
Contact information is provided by the study sponsor or research team.
Aleksander Heltne
CONTACT
Tine Nordgreen
CONTACT
Haukeland University Hospital
Other
A Therapist Guided Internet-delivered Treatment for Adults With ADHD - an Open Effectiveness Trial in Routine Care
Acronym: MinADHD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06081348
22Q11 Deletion, 22q11 Deletion Syndrome
Calgary, Alberta, Canada
View Trial DetailsNCT06797570
ADD, ADHD
View Trial DetailsNCT05452954
ADHD, ADHD - Combined Type
Groningen, Netherlands
View Trial DetailsNCT05631626
ADHD, ADHD - Combined Type
Las Vegas, Nevada, United States
View Trial Details